Author | Hendrik-Tobias Arkenau, MD, PhD | OncLive

Author | Hendrik-Tobias Arkenau, MD, PhD

Articles

Dr. Arkenau on the Potential of Immunotherapy in Gastric Cancer

December 06, 2018

Video

Hendrik-Tobias Arkenau, MD, PhD, medical director, Sarah Cannon Research Institute UK, discusses the potential of immunotherapy in gastric cancer.

Dr. Arkenau on Survival Data With TAS-102 in Gastric Cancer

October 21, 2018

Video

Hendrik-Tobias Arkenau, MD, PhD, medical director, Sarah Cannon Research Institute UK, discusses survival data with TAS-102 (trifluridine/tipiracil; Lonsurf) in gastric cancer at the 2018 ESMO Congress.

Dr. Arkenau on Advancements on Horizon in Gastric Cancer

July 27, 2016

Video

Hendrik-Tobias Arkenau, MD, PhD, founding medical director, executive medical director, Sarah Cannon Research Institute UK, discusses immunotherapy advancements on the horizon in the field of gastric cancer.

Dr. Arkenau on Dabrafenib Combined With Trametinib for BRAF-mutated Melanoma

July 07, 2015

Video

Hendrik-Tobias Arkenau, MD, PhD, executive medical director, Drug Development Unit, Sarah Cannon Research Institute-United Kingdom, discusses the overall survival results of the COMBI-d study, which examined the combination of dabrafenib and trametinib for the treatment of patients with unresectable or metastatic BRAF V600-mutated melanoma.

x